SPHR-SAR-Net: Superpixel High-resolution SAR Imaging Network Based on Nonlocal Total Variation

High-resolution is a key trend in the development of synthetic aperture radar (SAR), which enables the capture of fine details and accurate representation of backscattering properties. However, traditional high-resolution SAR imaging algorithms face several challenges. Firstly, these algorithms tend to focus on local information, neglecting non-local information between different pixel patches. Secondly, speckle is more pronounced and difficult to filter out in high-resolution SAR images. Thirdly, the process of high-resolution SAR imaging generally involves high time and computational complexity, making real-time imaging difficult to achieve. To address these issues, we propose a Superpixel High-Resolution SAR Imaging Network (SPHR-SAR-Net) for rapid despeckling in high-resolution SAR mode. Based on the concept of superpixel techniques, we initially combine non-convex and non-local total variation as compound regularization. This approach more effectively despeckles and manages the relationship between pixels while reducing bias effects caused by convex constraints. Subsequently, we solve the compound regularization model using the Alternating Direction Method of Multipliers (ADMM) algorithm and unfold it into a Deep Unfolded Network (DUN). The network's parameters are adaptively learned in a data-driven manner, and the learned network significantly increases imaging speed. Additionally, the Deep Unfolded Network is compatible with high-resolution imaging modes such as spotlight, staring spotlight, and sliding spotlight. In this paper, we demonstrate the superiority of SPHR-SAR-Net through experiments in both simulated and real SAR scenarios. The results indicate that SPHR-SAR-Net can rapidly perform high-resolution SAR imaging from raw echo data, producing accurate imaging results

Single-cell transcriptomics reveals receptor transformations during olfactory neurogenesis

The sense of smell allows chemicals to be perceived as diverse scents. We used single neuron RNA-Sequencing (RNA-Seq) to explore developmental mechanisms that shape this ability as nasal olfactory neurons mature in mice. Most mature neurons expressed only one of the roughly 1000 odorant receptor genes (Olfrs) available, and that at high levels. However, many immature neurons expressed low levels of multiple Olfrs. Coexpressed Olfrs localized to overlapping zones of the nasal epithelium, suggesting regional biases, but not to single genomic loci. A single immature neuron could express Olfrs from up to seven different chromosomes. The mature state in which expression of Olfr genes is restricted to one per neuron emerges over a developmental progression that appears independent of neuronal activity requiring sensory transduction molecules

A new simplified and robust Surface Reflectance Estimation Method (SREM) for use over diverse land surfaces using multi-sensor data

Surface reflectance (SR) estimation is the most critical pre-processing step for deriving geophysical parameters in multi-sensor remote sensing. Most state-of-the-art SR estimation methods, such as the vector version of the Second Simulation of the Satellite Signal in the Solar Spectrum (6SV) Radiative Transfer (RT) model, depend on accurate information on aerosol and atmospheric gases. In this study, a Simplified and Robust Surface Reflectance Estimation Method (SREM) based on the equations from 6SV RT model, without integrating information of aerosol particles and atmospheric gasses, is proposed and tested using Landsat 5 Thematic Mapper (TM), Landsat 7 Enhanced Thematic Mapper plus (ETM+), and Landsat 8 Operational Land Imager (OLI) data from 2000 to 2018. For evaluation purposes, (i) the SREM SR retrievals are validated against in-situ SR measurements collected by Analytical Spectral Devices (ASD) for the South Dakota State University (SDSU) site, USA (ii) cross-comparison between the SREM and Landsat spectral SR products, i.e., Landsat Ecosystem Disturbance Adaptive Processing System (LEDAPS) and Landsat 8 Surface Reflectance Code (LaSRC), are conducted over 11 urban (2013-2018), 13 vegetated (2013-2018), and 11 desert/arid (2000 to 2018) sites located over different climatic zones at global scale, (iii) the performance of the SREM spectral SR retrievals for low to high aerosol loadings is evaluated, (iv) spatio-temporal cross-comparison is conducted for six Landsat paths/rows located in Asia, Africa, Europe, and the USA from 2013 to 2018 to consider a large variety of land surfaces and atmospheric conditions, (v) cross-comparison is also performed for the Normalized Difference Vegetation Index (NDVI), the Enhanced Vegetation Index (EVI), and the Soil Adjusted Vegetation Index (SAVI) calculated from both the SREM and Landsat SR data, (vi) the SREM is also applied to the Sentinel-2A and Moderate Resolution Imaging Spectrometer (MODIS) data to explore its applicability, and (vii) errors in the SR retrievals are reported using the Mean Bias Error (MBE), Root Mean Squared Deviation (RMSD) and Mean Systematic Error (MSE). Results depict significant and strong positive Pearson’s correlation (r), small MBE, RMSD, and MSE for each spectral band against in-situ ASD data and Landsat (LEDAPS and LaSRC) SR products. Consistency in SREM performance against Sentinel-2A (r = 0.994, MBE = - 0.009, and RMSD = 0.014) and MODIS (r = 0.925, MBE = 0.007, and RMSD = 0.014) data suggests that SREM can be applied to other multispectral satellites data. Overall, the findings demonstrate the potential and promise of SREM for use over diverse surfaces and under varying atmospheric conditions using multi-sensor data on a global scale

The role of tumor-associated macrophages in glioma cohort: through both traditional RNA sequencing and single cell RNA sequencing

Gliomas are the leading cause in more than 50% of malignant brain tumor cases. Prognoses, recurrences, and mortality are usually poor for gliomas that have malignant features. In gliomas, there are four grades, with grade IV gliomas known as glioblastomas (GBM). Currently, the primary methods employed for glioma treatment include surgical removal, followed by chemotherapy after the operation, and targeted therapy. However, the outcomes of these treatments are unsatisfactory. Gliomas have a high number of tumor-associated macrophages (TAM), which consist of brain microglia and macrophages, making them the predominant cell group in the tumor microenvironment (TME). The glioma cohort was analyzed using single-cell RNA sequencing to quantify the genes related to TAMs in this study. Furthermore, the ssGSEA analysis was utilized to assess the TAM-associated score in the glioma group. In the glioma cohort, we have successfully developed a prognostic model consisting of 12 genes, which is derived from the TAM-associated genes. The glioma cohort demonstrated the predictive significance of the TAM-based risk model through survival analysis and time-dependent ROC curve. Furthermore, the correlation analysis revealed the significance of the TAM-based risk model in the application of immunotherapy for individuals diagnosed with GBM. Ultimately, the additional examination unveiled the prognostic significance of PTX3 in the glioma group, establishing it as the utmost valuable prognostic indicator in patients with GBM. The PCR assay revealed the PTX3 is significantly up-regulated in GBM cohort. Additionally, the assessment of cell growth further confirms the involvement of PTX3 in the GBM group. The analysis of cell proliferation showed that the increased expression of PTX3 enhanced the ability of glioma cells to proliferate. The prognosis of glioblastomas and glioma is influenced by the proliferation of tumor-associated macrophages

The Effectiveness of Pay-It-Forward in Addressing HPV Vaccine Delay and Increasing Uptake Among 15–18-Year-Old Adolescent Girls Compared to User-Paid Vaccination: A Study Protocol for a Two-Arm Randomized Controlled Trial in China

Background Human papillomavirus (HPV) vaccination could prevent cervical and other HPV-associated cancers attributable to vaccine-associated HPV types. However, HPV vaccination coverage among women aged 9–18 years old is low in China. Common barriers include poor financial affordability, minimal public engagement, and low confidence in domestically produced HPV vaccines. Pay-it-forward offers an individual a free or subsidized service then an opportunity to voluntarily donate and/or create a postcard message to support future people. This study aims to assess the effectiveness of pay-it-forward as compared to standard-of-care self-paid vaccination to improve HPV vaccine uptake among adolescent girls aged 15–18 years, who are left out in the current pilot free HPV vaccination task force in some parts of China. Methods This is a two-arm randomized controlled trial in Chengdu, China. Eligible adolescent girls (via caregivers) will be randomly selected and recruited through four community health centers (one in the most developed urban areas, one in higher middle-income and one in lower middle-income suburban areas, and one in the least developed rural areas) using the resident registration list. A total of 320 participants will be randomized into two study arms (user-paid versus pay-it-forward vaccination) in a 1:1 ratio. The intervention assignment will be blinded to recruiters and participants using envelop concealment until the research assistants open the envelop to determine which treatment to deliver to each individual. The primary outcome of the study will be HPV vaccine uptake by administrative data. Secondary outcomes include costs, vaccine hesitancy, and the completion rates of the 3-dose HPV vaccination series. Discussion This study will investigate an innovative pay-it-forward strategy’s effectiveness and economic costs to improve HPV vaccination among 15–18-year-old adolescent girls. Study findings will have implications for increasing HPV vaccine uptake in places where HPV vaccines are provided for a fee

Analysis of the IDS Gene in 38 Patients with Hunter Syndrome: The c.879G>A (p.Gln293Gln) Synonymous Variation in a Female Create Exonic Splicing

BACKGROUND: Hunter syndrome (mucopolysaccharidosis type II, MPS II) is a rare disease inherited in an X-linked autosomal recessive pattern. It is the prevailing form of the mucopolysaccharidoses in China. Here we investigated mutations of IDS (iduronate 2-sulfatase) gene in 38 unrelated Chinese patients, one of which is a female. METHODS: Peripheral leucocytes were collected from the patients and the IDS gene was amplified to looking for the variations. For a female patient, the X chromosome status was analyzed by androgen receptor X-inactivation assay and the mutation impact on RNA level was further performed by reverse transcription polymerase chain reaction. RESULTS: We discovered that point mutations constituted the major form while mutations in codon p.R468 defined the largest number of patients in our cohort. Consistent with data from other ethnic groups, exons 9 and 3 had comparatively more mutations, while exon 2 had quite a few mutations unique to Chinese patients. Of the 30 different mutations identified, only 9 were novel: one was a premature termination mutation, i.e., c.196C>T (p.Gln66X); three were missense mutations, i.e., c.200T>C (p.Leu67Pro), c.215T>C (p.Leu72Pro), c.389C>T (p.Thr130Ile); one was a small deletion, i.e., c.1104_1122del19 (p.Ser369ArgfsX16); and one was a deletion that spanned both exons 8 and 9 deletion leading to gross structural changes in the IDS gene. In addition, a synonymous mutation c.879G>A (p.Gln293Gln) was identified in a female Hunter disease patient, which resulted in loss of the original splicing site, activated a cryptic splicing site upstream, leading to a 28 bp deletion and a premature termination at p. Tyr285GlufsX47. Together with concurrent skewed X-inactivation this was believed to facilitate the development of Hunter disease in this girl. CONCLUSIONS: In conclusion, the molecular analysis of IDS gene in Chinese patients confirmed the Hunter disease diagnosis and expanded the mutation and clinical spectrum of this devastating disorder

The effectiveness of pay-it-forward in addressing HPV vaccine delay and increasing uptake among 15-18-year-old adolescent girls compared to user-paid vaccination: a study protocol for a two-arm randomized controlled trial in China

BACKGROUND: Human papillomavirus (HPV) vaccination could prevent cervical and other HPV-associated cancers attributable to vaccine-associated HPV types. However, HPV vaccination coverage among women aged 9-18 years old is low in China. Common barriers include poor financial affordability, minimal public engagement, and low confidence in domestically produced HPV vaccines. Pay-it-forward offers an individual a free or subsidized service then an opportunity to voluntarily donate and/or create a postcard message to support future people. This study aims to assess the effectiveness of pay-it-forward as compared to standard-of-care self-paid vaccination to improve HPV vaccine uptake among adolescent girls aged 15-18 years, who are left out in the current pilot free HPV vaccination task force in some parts of China. METHODS: This is a two-arm randomized controlled trial in Chengdu, China. Eligible adolescent girls (via caregivers) will be randomly selected and recruited through four community health centers (one in the most developed urban areas, one in higher middle-income and one in lower middle-income suburban areas, and one in the least developed rural areas) using the resident registration list. A total of 320 participants will be randomized into two study arms (user-paid versus pay-it-forward vaccination) in a 1:1 ratio. The intervention assignment will be blinded to recruiters and participants using envelop concealment until the research assistants open the envelop to determine which treatment to deliver to each individual. The primary outcome of the study will be HPV vaccine uptake by administrative data. Secondary outcomes include costs, vaccine hesitancy, and the completion rates of the 3-dose HPV vaccination series. DISCUSSION: This study will investigate an innovative pay-it-forward strategy's effectiveness and economic costs to improve HPV vaccination among 15-18-year-old adolescent girls. Study findings will have implications for increasing HPV vaccine uptake in places where HPV vaccines are provided for a fee. TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR), ChiCTR2200055542. Registered on 11 January 2022

A longitudinal resource for population neuroscience of school-age children and adolescents in China

During the past decade, cognitive neuroscience has been calling for population diversity to address the challenge of validity and generalizability, ushering in a new era of population neuroscience. The developing Chinese Color Nest Project (devCCNP, 2013–2022), the first ten-year stage of the lifespan CCNP (2013–2032), is a two-stages project focusing on brain-mind development. The project aims to create and share a large-scale, longitudinal and multimodal dataset of typically developing children and adolescents (ages 6.0–17.9 at enrolment) in the Chinese population. The devCCNP houses not only phenotypes measured by demographic, biophysical, psychological and behavioural, cognitive, affective, and ocular-tracking assessments but also neurotypes measured with magnetic resonance imaging (MRI) of brain morphometry, resting-state function, naturalistic viewing function and diffusion structure. This Data Descriptor introduces the first data release of devCCNP including a total of 864 visits from 479 participants. Herein, we provided details of the experimental design, sampling strategies, and technical validation of the devCCNP resource. We demonstrate and discuss the potential of a multicohort longitudinal design to depict normative brain growth curves from the perspective of developmental population neuroscience. The devCCNP resource is shared as part of the “Chinese Data-sharing Warehouse for In-vivo Imaging Brain” in the Chinese Color Nest Project (CCNP) – Lifespan Brain-Mind Development Data Community (https://ccnp.scidb.cn) at the Science Data Bank